Risk Factors of Death in Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacterales in Patients with Neoplasia

• Published in: Infection and drug resistance Vol. 14; pp. 3083 - 3097
• Main Authors: Cunha Ferreira, Tiago da, Martins, Ianick Souto
• Format: Journal Article
• Language: English
• Published: Macclesfield Taylor & Francis Ltd 01-01-2021; Dove; Dove Medical Press
• Subjects: Antibiotics; Bacterial infections; cancer; Catheters; Chemotherapy; Data collection; Death; Disease; Enterobacter; Enterobacterales; Gastrointestinal tract; Hemodialysis; Hospitalization; Hospitals; Laboratories; Medical records; Mortality; Multidrug resistance; Nosocomial infections; Original Research; Patients; Piperacillin; Piperacillin-tazobactam; Radiation therapy; Risk factors; Serratia; Solid tumors; Tazobactam; β Lactamase; β-lactamases
• ISSN: 1178-6973; 1178-6973
• DOI: 10.2147/IDR.S312920

Purpose: The infections caused by ESCPM Enterobacterales (Enterobacter spp., Serratia spp., Citrobacter spp., Providencia spp. and Morganella spp.) have limited therapeutic options. Patients with neoplastic diseases are particularly vulnerable to bloodstream infections (BSIs). Objective: To analyze determinant factors of death in patients with neoplasia complicated with BSI caused by ESCPM Enterobacterales. Patients and Methods: A cohort study of patients aged 18 years or older with neoplasia and BSI due to ESCPM group was conducted at the Cancer Hospital I of the National Cancer Institute, Brazil, from September 2012 to December 2017. The variables associated with death were analyzed using multivariate logistic regression. Results: Of the 103 patients included in the cohort, 67.0% were male, the median age was 63 years and 67.0% had solid tumors. Of the 107 BSI episodes evaluated, 70.1% were hospital-acquired infections, 54.2% were secondary to extravascular focus of infection, gastrointestinal tract (19.6%), mainly. Enterobacter spp. (n: 49, 45.4%) was the most frequent agent isolated followed by Serratia spp. (n: 34, 31.5%), Morganella morganii (n: 16, 14.9%), Citrobacter freundii. (n: 7, 6.5%) and Providencia spp. (n: 2, 1.8%). Ten (9.3%) BSI episodes were caused by multidrug-resistant ESCPM Enterobacterales (MDR-ESCPM). The 7-day and 30-day mortality were 9.3% and 21.5%, respectively. The BSIs caused by MDR-ESCPM were independently associated with 7-day death (OR = 21.62 95% CI: 1.81– 258.51 P = 0.01). Monotherapy with piperacillin-tazobactam tended to be associated with 7-day death (OR = 10.46 95% CI: 0.97– 112.91 P = 0.05) and 30-day death (OR = 2.73 95% CI: 0.96– 7.70 P = 0.05). Conclusion: BSIs due to ESCPM group have high mortality and when caused by MDR-ESCPM are independently associated with 7-day death. The possible association of piperacillin-tazobactam monotherapy for BSI-ESCPM with death needs to be better studied.